Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 4/28/2026China Accelerates Biobank Buildout as Data Becomes Strategic Asset in ...
  • 4/28/2026Sun Pharma's $11.75B Organon Deal Signals Major Push Into China Market
  • 4/28/2026Gritgen Reports Durable Efficacy of Hemophilia A Gene Therapy at WFH 2...
  • 4/28/2026QL Biopharma Files Hong Kong IPO to Advance Next-Gen Metabolic Pipelin...
  • 4/28/2026Hengrui Launches Large-Scale Phase 3 Trial of GLP-1/GIP Agonist HRS953...
  • 4/28/2026Seven Novel Drug Candidates Win IND Clearance in China Across Modaliti...
  • 4/28/2026Simcere Withdraws and Plans Rapid Resubmission of Rademikibart NDA in ...
  • 4/28/2026Theia Reports Early Clinical Progress for iPSC-Derived Cell Therapy in...
  • 4/27/2026China's Basic Medical Insurance Fund Records Strong Surplus in Q1 2026
  • 4/27/2026Former Jiangxi Provincial Health Commission Chief Dismissed/Investigat...
  • 4/27/2026China NMPA Releases Updated Procedures for Conditional Drug Approvals
  • 4/27/2026Adcoris Out-Licenses 5T4 ADC to NewCo in Global Deal with K2 Therapeut...
  • 4/27/2026Novamab Raises ~CNY 300M Series B+ to Advance Inhaled and Oral Nanobod...
  • 4/24/2026China Seeks Feedback on New Approval Framework for Clinical Translati...
  • 4/24/2026CDE Issues New Framework for Post-Approval Changes and Registration Te...
  • 4/24/2026Recent Executive Moves
  • 4/23/2026Transcenta Showcases Preclinical Data for LIV1 ADC TST013 at AACR 2026
  • 4/23/20263D Medicines Presents Early Clinical and Preclinical Data for ¹⁷⁷Lu...
  • 4/23/2026Hexaell Raises ~CNY 100M in B+ Round to Advance Bio-Artificial Liver P...
  • 4/23/2026CDE Issues New Guidance Table on Post-Approval Changes and Triggering ...
  • 4/23/2026Chinese API Makers Raise Prices as Middle East Conflict Drives Up Raw ...
  • 4/23/2026Teva Partners with NeuroGen to Expand Migraine Drug Ajovy in China
  • 4/23/2026Tortugas Neuroscience Launches with $106M to Advance China- and Japan-...
  • 4/22/2026Binhui Biopharma Files HKEX IPO, Highlighting HSV-2 Oncolytic Virus Pl...
  • 4/22/2026InxMed Files for Hong Kong IPO, Showcasing Late-Stage Oncology Pipelin...
  • 4/22/2026CDE Opens Public Consultation on 106th Batch of Reference Formulations...
  • 4/22/2026China Suspends Import and Use of Colchicine API from Two Indian Manufa...
  • 4/22/2026Pfizer Enters China's Booming GLP-1 Market with Pre-Orders for Weight-...
  • 4/22/2026Chinese Biotech Firms Challenge Western Lead in $16B Parkinson's Treat...
  • 4/22/2026China Unveils Landmark Drug Pricing Framework to Boost Innovation and ...
  • Page:1/62 Total number of articles:1849: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group